For: | Tsochatzis EA, Papatheodoridis GV. Is there any progress in the treatment of non-alcoholic fatty liver disease? World J Gastrointest Pharmacol Ther 2011; 2(1): 1-5 [PMID: 21577310 DOI: 10.4292/wjgpt.v2.i1.1] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v2/i1/1.htm |
Number | Citing Articles |
1 |
Shu-yu Yang, Neng-jiang Zhao, Xue-jun Li, Hui-jie Zhang, Ke-ji Chen, Can-dong Li. Ping-tang Recipe (平糖方) improves insulin resistance and attenuates hepatic steatosis in high-fat diet-induced obese rats. Chinese Journal of Integrative Medicine 2012; 18(4): 262 doi: 10.1007/s11655-012-1023-0
|
2 |
Maryam jarhahzadeh, Pezhman Alavinejad, Farnaz Farsi, Durdana Husain, Afshin Rezazadeh. The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial. Diabetology & Metabolic Syndrome 2021; 13(1) doi: 10.1186/s13098-021-00731-7
|
3 |
Liang Ma, Jinying Chen, Xiaolin Liang, Caifei Xie, Chongyang Deng, Li Huang, Aihua Peng, Yuanquan Wei, Lijuan Chen. Synthesis and Evaluation of 5‐Benzylidenethiazolidine‐2,4‐dione Derivatives for the Treatment of Non‐Alcoholic Fatty Liver Disease. Archiv der Pharmazie 2012; 345(7): 517 doi: 10.1002/ardp.201100413
|
4 |
Jelena Stevanović, Jorge Beleza, Pedro Coxito, António Ascensão, José Magalhães. Physical exercise and liver “fitness”: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease. Molecular Metabolism 2020; 32: 1 doi: 10.1016/j.molmet.2019.11.015
|
5 |
Inês O. Gonçalves, Paulo J. Oliveira, António Ascensão, José Magalhães. Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis. European Journal of Clinical Investigation 2013; 43(11): 1184 doi: 10.1111/eci.12146
|
6 |
Humaira B. Noor, Nusrat A. Mou, Liyad Salem, Md F.A. Shimul, Soumick Biswas, Rowshon Akther, Salma Khan, Sabbir Raihan, Md M. Mohib, Md A.T. Sagor. Anti-inflammatory Property of AMP-activated Protein Kinase. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2020; 19(1): 2 doi: 10.2174/1871523018666190830100022
|
7 |
Alessandro Federico, Claudio Zulli, Ilario de Sio, Anna Del Prete, Marcello Dallio, Mario Masarone, Carmela Loguercio. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(45): 16841-16857 doi: 10.3748/wjg.v20.i45.16841
|
8 |
C. S. Pitchumoni, C. S. Pitchumoni, C. S. Pitchumoni. Geriatric Gastroenterology. 2012; : 399 doi: 10.1007/978-1-4419-1623-5_40
|
9 |
François Briand, Quentin Thiéblemont, Elodie Muzotte, Thierry Sulpice. High-Fat and Fructose Intake Induces Insulin Resistance, Dyslipidemia, and Liver Steatosis and Alters In Vivo Macrophage-to-Feces Reverse Cholesterol Transport in Hamsters. The Journal of Nutrition 2012; 142(4): 704 doi: 10.3945/jn.111.153197
|
10 |
Ya. M. Vakhrushev, E. V. Suchkova, А. Р. Lukashevich. Clinical and prognostic value of metabolic disorders in non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2020; 92(12): 31 doi: 10.26442/00403660.2020.12.200444
|